Hepatitis B News and Research

Latest Hepatitis B News and Research

As syphilis invades rural America, a fraying health safety net is failing to stop it

When Karolyn Schrage first heard about the "dominoes gang" in the health clinic she runs in Joplin, Mo., she assumed it had to do with pizza.

19 Apr 2019

Innate immune sensor responding to gut microbes can suppress liver cancer

UT Southwestern researchers have found that a protein in the body's innate immune system that responds to gut microbes can suppress the most common type of liver cancer.

17 Apr 2019

Researchers discover how liver cells protect against viral attacks

Liver cells have an innate resistance to RNA viral infections like hepatitis A, dengue and Zika thanks to a protein called IRF1, according to researchers at the University of North Carolina at Chapel Hill and Tokyo Metropolitan Institute of Medical Science.

16 Apr 2019

New technique uses UV and red light to decontaminate organs before transplantation

A new technique for the decontamination of organs before transplantation using ultraviolet and red light irradiation has been developed by Brazilian and Canadian researchers and is described in an article published in the journal Nature Communications.

12 Apr 2019

New study provides overview of potential risks of vaccinating breastfeeding women

In light of the continuing anti-vaccination movement, a provocative new article provides a comprehensive overview of the potential risks of vaccinating breastfeeding women.

11 Apr 2019

Hepatitis C infections could be reduced by stepping up efforts to prevent transmission in people who inject drugs

Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43 per cent globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today [Tuesday 9 April 2019].

10 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.

9 Apr 2019

Cellular protein could take on role of restriction factor for hepatitis B virus

Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not curative for infected individuals.

8 Apr 2019

Rising rates of liver cancer deaths largely confined to individuals with less education

A new study reveals that rising rates of liver cancer deaths in the United States have largely been confined to individuals who have received less education, especially among men.

8 Apr 2019

Heart and lung transplants from hepatitis-C infected donors considered safe

A recent trial has shown that heart and lungs from donors infected with hepatitis C can be safely transplanted, without recipients becoming infected with the virus.

5 Apr 2019

Opioid epidemic fuels growing rates of some infectious diseases

The United States faces a converging public health crisis as the nation's opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

4 Apr 2019

Hepatitis C-infected thoracic organs can be safely transplanted, study finds

Infectious diseases experts and transplant physicians and surgeons at Brigham and Women's Hospital have blocked the transmission of hepatitis C from infected organ donors to recipients in need of hearts or lungs.

4 Apr 2019

Study uncovers genetic variant associated with liver fibrosis in chronic hepatitis C patients

A new study from The Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. This finding is a step toward reducing the number of patients requiring liver transplants.

3 Apr 2019

European surveillance data shows slight decrease in newly reported hepatitis C cases

European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31 000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area.

2 Apr 2019

WHO guidelines for chronic hepatitis B fail to detect half of the patients in Ethiopia needing treatment

Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier.

29 Mar 2019

New strategy for potential treatment of HBV associated liver cancer

Researchers from Duke-NUS Medical School, Singapore General Hospital and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found in the body, to treat Hepatocellular carcinoma, a commonly occurring liver cancer.

28 Mar 2019

Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons

New research identifies guidelines for prioritizing the treatment of hepatitis C infections in the U.S. prison system, resulting in a significant improvement in health outcomes of incarcerated persons while simultaneously reducing new infections in the society.

22 Mar 2019

Mayo Clinic study identifies potential new drug therapy for liver diseases

Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers.

22 Mar 2019

NIH starts clinical trial of drug to treat cravings associated with opioid use disorder

A clinical trial of an experimental drug designed to treat cravings associated with opioid use disorder has begun in the National Institutes of Health Clinical Center.

22 Mar 2019

Hepatitis B News and Research

Latest Hepatitis B News and Research

As syphilis invades rural America, a fraying health safety net is failing to stop it

Innate immune sensor responding to gut microbes can suppress liver cancer

Researchers discover how liver cells protect against viral attacks

New technique uses UV and red light to decontaminate organs before transplantation

New study provides overview of potential risks of vaccinating breastfeeding women

Hepatitis C infections could be reduced by stepping up efforts to prevent transmission in people who inject drugs

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

FDA approves two-drug complete regimen for previously untreated HIV-infected adults

Cellular protein could take on role of restriction factor for hepatitis B virus

Rising rates of liver cancer deaths largely confined to individuals with less education

Heart and lung transplants from hepatitis-C infected donors considered safe

Opioid epidemic fuels growing rates of some infectious diseases

Hepatitis C-infected thoracic organs can be safely transplanted, study finds

Study uncovers genetic variant associated with liver fibrosis in chronic hepatitis C patients

European surveillance data shows slight decrease in newly reported hepatitis C cases

WHO guidelines for chronic hepatitis B fail to detect half of the patients in Ethiopia needing treatment

New strategy for potential treatment of HBV associated liver cancer

Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons

Mayo Clinic study identifies potential new drug therapy for liver diseases

NIH starts clinical trial of drug to treat cravings associated with opioid use disorder

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Hepatitis B News and Research

Latest Hepatitis B News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in